MX9307079A - Mejoras en composiciones farmaceuticas para el tratamiento de trastornos funcionales de las vias intestinales y mejoras en un procedimiento para la preparacion de dichas composiciones. - Google Patents

Mejoras en composiciones farmaceuticas para el tratamiento de trastornos funcionales de las vias intestinales y mejoras en un procedimiento para la preparacion de dichas composiciones.

Info

Publication number
MX9307079A
MX9307079A MX9307079A MX9307079A MX9307079A MX 9307079 A MX9307079 A MX 9307079A MX 9307079 A MX9307079 A MX 9307079A MX 9307079 A MX9307079 A MX 9307079A MX 9307079 A MX9307079 A MX 9307079A
Authority
MX
Mexico
Prior art keywords
compositions
intestinal
ways
procedure
preparation
Prior art date
Application number
MX9307079A
Other languages
English (en)
Inventor
Christian Eeckhout
Ulf Preuschoff
Samuel David
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of MX9307079A publication Critical patent/MX9307079A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Mejoras en composiciones farmacéuticas para el tratamiento de trastornos funcionales de las vías intestinales inferiores ligadas con una algesia incrementada y/o anomalías del paso de las heces en la zona del colon en mamíferos superiores y en seres humanos, caracterizadas por el hecho que comprende compuestos de imidazol-1-ilo-de la fórmula general I en donde R1 significa alquilo inferior o hidrógeno, m representa 2 ó 3 y n representa 2 ó 3, y sus sales por adición de ácidos fisiológicamente compatibles.
MX9307079A 1992-11-14 1993-11-12 Mejoras en composiciones farmaceuticas para el tratamiento de trastornos funcionales de las vias intestinales y mejoras en un procedimiento para la preparacion de dichas composiciones. MX9307079A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4238553A DE4238553A1 (de) 1992-11-14 1992-11-14 Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
MX9307079A true MX9307079A (es) 1994-05-31

Family

ID=6472938

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9307079A MX9307079A (es) 1992-11-14 1993-11-12 Mejoras en composiciones farmaceuticas para el tratamiento de trastornos funcionales de las vias intestinales y mejoras en un procedimiento para la preparacion de dichas composiciones.

Country Status (24)

Country Link
US (1) US5438068A (es)
EP (1) EP0601345B1 (es)
JP (1) JP3683286B2 (es)
KR (1) KR100266715B1 (es)
CN (1) CN1041053C (es)
AT (1) ATE143597T1 (es)
AU (1) AU667243B2 (es)
CA (3) CA2504502A1 (es)
CZ (1) CZ284154B6 (es)
DE (2) DE4238553A1 (es)
DK (1) DK0601345T3 (es)
DZ (1) DZ1726A1 (es)
ES (1) ES2092206T3 (es)
GR (1) GR3021230T3 (es)
HK (1) HK1006537A1 (es)
HU (1) HU213506B (es)
IL (1) IL107454A (es)
MX (1) MX9307079A (es)
NO (1) NO303926B1 (es)
NZ (1) NZ250103A (es)
PH (1) PH30702A (es)
RU (1) RU2125877C1 (es)
SK (1) SK278874B6 (es)
ZA (1) ZA938463B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365743B1 (en) 1995-10-13 2002-04-02 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
DE19813661A1 (de) * 1997-08-01 1999-02-04 Solvay Pharm Gmbh Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US7015333B2 (en) * 2002-11-18 2006-03-21 Solvay Pharmaceuticals B.V. Process for preparation of imidazolyl compounds
EP1424337A1 (en) * 2002-11-26 2004-06-02 Solvay Pharmaceuticals GmbH 4-hydroxy derivatives of 5,6,9,10-tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-one
EP1558081A4 (en) * 2003-01-13 2006-06-14 Dynogen Pharmaceuticals Inc METHOD OF TREATING FUNCTIONAL INTESTINAL DISORDERS
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0201165B1 (en) * 1985-03-14 1994-07-20 Beecham Group Plc Medicaments for the treatment of emesis
ES2059491T3 (es) * 1987-06-29 1994-11-16 Duphar Int Res Derivados de indol con anillos condensados.

Also Published As

Publication number Publication date
EP0601345B1 (de) 1996-10-02
DZ1726A1 (fr) 2002-02-17
ES2092206T3 (es) 1996-11-16
SK278874B6 (sk) 1998-04-08
JPH06211656A (ja) 1994-08-02
CA2102960A1 (en) 1994-05-15
NZ250103A (en) 1997-06-24
US5438068A (en) 1995-08-01
AU5064393A (en) 1994-05-26
GR3021230T3 (en) 1997-01-31
CZ284154B6 (cs) 1998-08-12
CA2538177A1 (en) 1994-05-15
NO303926B1 (no) 1998-09-28
CA2102960C (en) 2005-08-02
IL107454A (en) 1999-12-22
DE4238553A1 (de) 1994-05-19
NO934090L (es) 1994-05-16
DE59304045D1 (de) 1996-11-07
CA2504502A1 (en) 1994-05-15
HU213506B (en) 1997-07-28
PH30702A (en) 1997-09-16
NO934090D0 (no) 1993-11-12
AU667243B2 (en) 1996-03-14
DK0601345T3 (da) 1996-11-18
HK1006537A1 (en) 1999-03-05
CN1041053C (zh) 1998-12-09
CZ236593A3 (en) 1994-05-18
EP0601345A1 (de) 1994-06-15
ATE143597T1 (de) 1996-10-15
ZA938463B (en) 1994-08-01
HUT65978A (en) 1994-08-29
RU2125877C1 (ru) 1999-02-10
CN1092650A (zh) 1994-09-28
IL107454A0 (en) 1994-02-27
KR940010999A (ko) 1994-06-20
JP3683286B2 (ja) 2005-08-17
KR100266715B1 (ko) 2000-09-15
SK123593A3 (en) 1994-09-07

Similar Documents

Publication Publication Date Title
FI935134A (fi) Substituerade 3-aminokinuklidiner
MX9307079A (es) Mejoras en composiciones farmaceuticas para el tratamiento de trastornos funcionales de las vias intestinales y mejoras en un procedimiento para la preparacion de dichas composiciones.
ATE183496T1 (de) Amidderivate und ihre therapeutische verwendung
FI92320C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten bisfenyylialkyylipiperatsiinijohdannaisten valmistamiseksi
RU93052161A (ru) Лекарственные средства, содержащие производные имидазол-1-ила
ATE190845T1 (de) Rektale flunisolid-zubereitung zur behandlung entzündlicher darmerkrankungen

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees